Feature Channels: Infectious Diseases

Filters close
Released: 7-Feb-2023 4:05 PM EST
Employing tradeoffs for more realistic COVID messaging
Cornell University

A Cornell University economist conducted an experiment with nearly 700 people in three countries to gauge the public’s perception of relative risk factors.

Released: 7-Feb-2023 4:05 PM EST
Night staff at nursing homes had lower rates of COVID-19 testing, vaccination than day shift
Brown University

An analysis led by Brown University researchers showed that work shift is an important factor to consider when designing workplace health interventions.

Released: 7-Feb-2023 12:05 PM EST
Resilience to HIV-Related Stigma May Be Key to Ending the AIDS Epidemic
Rutgers University-New Brunswick

Failing to address the psychological trauma experienced by many older people living with HIV/AIDS will make it difficult, if not impossible, to end the epidemic, according to a Rutgers study.

Newswise: Optimal Layout for a Hospital Isolation Room to Contain COVID-19 Includes Ceiling Vent
2-Feb-2023 2:30 PM EST
Optimal Layout for a Hospital Isolation Room to Contain COVID-19 Includes Ceiling Vent
American Institute of Physics (AIP)

Researchers recently modeled the transmission of COVID-19 within an isolation room at the Royal Brompton Hospital in London, U.K. Their goal was to explore the optimal room layout to reduce the risk of infection for health care staff. To accomplish this, they used an adaptive mesh finite-element computational fluid dynamics model to simulate 3D spatial distribution of the virus within the room — based on data collected from the room during a COVID-19 patient’s stay. They share their findings and guidance in Physics of Fluids.

   
Released: 7-Feb-2023 9:00 AM EST
Speakers Announced for #DiscoverBMB
American Society for Biochemistry and Molecular Biology (ASBMB)

Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, will feature award lectures by high-profile speakers discussing noteworthy research, education and diversity initiatives. The meeting will take place March 25–28 in Seattle.

Released: 3-Feb-2023 12:20 PM EST
Sharing COVID-19 Experiences Can Increase Vaccination Rates
Rutgers University-New Brunswick

People who know someone who became ill with COVID-19 or died from the disease are twice as likely to receive a COVID-19 vaccine, according to a study led by Rutgers and Penn State University.

1-Feb-2023 1:30 PM EST
Estimated Effectiveness of CoronaVac, Pfizer-BioNTech Vaccines Over Time Among Patients With SARS-CoV-2 Omicron
JAMA - Journal of the American Medical Association

Few studies have evaluated the waning of vaccine effectiveness against severe outcomes caused by SARS-CoV-2 Omicron infection. Hong Kong is providing inactivated and mRNA vaccines, but the population had limited protection from natural infections before the Omicron variant emerged.

Released: 3-Feb-2023 10:00 AM EST
Long Covid Is Having A Significant Impact On The Workforce. Study Finds Three Years Into The Pandemic, Nearly 18% Of Long Covid Patients Haven’t Returned To Work
Hackensack Meridian Health

Labor statistics show long Covid is having a significant impact on American's ability to return to work. Hackensack Meridian's Covid Recovery Center discusses treatments they offer and how it has helped patients return to their normal lives.

Newswise: Harmful bacteria can elude predators when in mixed colonies
Released: 2-Feb-2023 7:10 PM EST
Harmful bacteria can elude predators when in mixed colonies
Dartmouth College

Efforts to fight disease-causing bacteria by harnessing their natural predators could be undermined when multiple species occupy the same space, according to a study by Dartmouth College researchers.

Released: 2-Feb-2023 3:45 PM EST
FSU Nursing awarded $72.7M NIH grant to lead adolescent HIV clinical trial network
Florida State University

Florida State University has been awarded a $72.7 million grant from the National Institutes of Health (NIH) to redesign and improve HIV prevention and care interventions in adolescents and young adults in the United States. Under the grant, which will be dispersed over the course of seven years, FSU will serve as the Scientific Leadership Center (SLC) for the Adolescent Medicine Trials Network for HIV Interventions.

Newswise: Breakthrough COVID-19 cases occur in 7.5% of vaccinated Texas participants, according to UTHealth Houston survey; subgroups at higher risk identified
Released: 2-Feb-2023 3:10 PM EST
Breakthrough COVID-19 cases occur in 7.5% of vaccinated Texas participants, according to UTHealth Houston survey; subgroups at higher risk identified
University of Texas Health Science Center at Houston

Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed and higher odds were associated with Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health published today in the Journal of Infectious Diseases.

Released: 2-Feb-2023 1:40 PM EST
Tuberculosis vaccine does not protect elderly against COVID-19
University Medical Center Utrecht

The tuberculosis vaccine (or BCG vaccine) does not protect elderly with co-morbidities against disease symptoms caused by a coronavirus infection.

Released: 1-Feb-2023 6:45 PM EST
Mapping Mexico’s Dengue Fever Hotspots
Rutgers University-New Brunswick

Ubydul Haque, an assistant professor of global health at the Rutgers Global Health Institute, has analyzed data from Mexico’s Ministry of Health to identify dengue fever hotspots. Working with epidemiologists at the University of North Texas and Universidad Autónoma de Nuevo León, the team calculated environmental and socioeconomic risk factors and mapped areas where severe outbreaks occur.

Released: 1-Feb-2023 5:25 PM EST
Immunocompromised patients remain at higher risk of COVID-19 death in hospital
University of Liverpool

People with weakened immune systems remain more likely to die if hospitalised with COVID-19 than patients with normal immune systems, a new UK study has confirmed.

26-Jan-2023 2:50 PM EST
Global antimicrobial use in animals could increase by 8% by 2030
PLOS

Despite concerns over antimicrobial resistance, global antimicrobial use in animals could increase by 8% by 2030.

   
Released: 1-Feb-2023 12:40 PM EST
Sepsis increased risk of heart failure and rehospitalization after hospital discharge
American Heart Association (AHA)

After hospital discharge, people hospitalized for sepsis or who developed it while hospitalized had a 38% higher risk of rehospitalization for all causes and a 43% higher risk of rehospitalization for cardiovascular causes compared to people without sepsis during hospitalization.

Released: 31-Jan-2023 5:05 PM EST
The latest research news on surgery and transplants
Newswise

Below are some of the latest articles that have been added to the Surgery and the Transplantation channels on Newswise, a free source for journalists.

Released: 31-Jan-2023 2:30 PM EST
Deer carry SARS-CoV-2 variants that are extinct in humans
Cornell University

Cornell University researchers have found white-tailed deer ­– the most abundant large mammal in North America – are harboring SARS-CoV-2 variants that were once widely circulated, but no longer found in humans.

Released: 31-Jan-2023 9:30 AM EST
Study Suggests Side-Effects and Costs Are Biggest Concerns for Users of HIV Pre-Exposure Prophylaxis
Johns Hopkins Bloomberg School of Public Health

A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting injections over pills, but rank side effects and costs as the most important issues for them in considering whether to take PrEP.

Newswise: Which test is best? Frequent versus infrequent testing for the Omicron variant of COVID-19
Released: 30-Jan-2023 8:10 PM EST
Which test is best? Frequent versus infrequent testing for the Omicron variant of COVID-19
Osaka University

Testing plays a crucial role in humanity’s strategy to mitigate the effects of widespread COVID-19 infection. However, given multiple options for testing and the emergence of the highly contagious Omicron variant, how do we choose which test to use?

Newswise: New drugs to squash the spread of malaria
Released: 30-Jan-2023 6:05 PM EST
New drugs to squash the spread of malaria
The Company of Biologists

Malaria is a devastating disease, with 247 million cases and 619,000 deaths reported in 2021 alone.

Released: 30-Jan-2023 5:20 PM EST
SLU Researcher Receives $1.76 Million NIH Grant to Create STAR, an HIV-Focused Experiential Research and Capacity Building Program for Students and Young Researchers
Saint Louis University Medical Center

Using a crowdsourcing framework utilized over the past five years, Juliet Iwelunmor, Ph.D., professor of global health and behavioral science and health education at Saint Louis University’s College for Public Health and Social Justice, is taking what she learned from empowering youth in Nigeria to identify young people in the United States who aim to become the next generation of HIV researchers, leaders and innovators in the field.

Not for public release

This news release is embargoed until 30-Jan-2023 5:00 PM EST Released to reporters: 24-Jan-2023 2:20 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Jan-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection
Released: 30-Jan-2023 4:30 PM EST
LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection
La Jolla Institute for Immunology

Inmazeb (REGN-EB3), developed by Regeneron, is a three-antibody cocktail designed to target the Ebola virus glycoprotein. The drug was first approved for clinical use in October 2020, but its exact mechanism of action has remained unclear.

   
Released: 30-Jan-2023 4:00 PM EST
90% reduction in COVID-19 deaths after booster dose: Hong Kong study
Canadian Medical Association Journal

A booster (third) dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple health conditions compared to 2 doses, according to a new study from Hong Kong published in CMAJ (Canadian Medical Association Journal).

Newswise: Measles virus 'cooperates' with itself to cause fatal encephalitis
Released: 27-Jan-2023 5:50 PM EST
Measles virus 'cooperates' with itself to cause fatal encephalitis
Kyushu University

Researchers in Japan have uncovered the mechanism for how the measles virus can cause subacute sclerosing panencephalitis, or SSPE, a rare but fatal neurological disorder that can occur several years after a measles infection.

Newswise: Vaccines protected pregnant women during Omicron surge
Released: 27-Jan-2023 3:35 PM EST
Vaccines protected pregnant women during Omicron surge
University of Washington School of Medicine and UW Medicine

The main point of the study, which was completed before other variants came on the scene, is for pregnant women to get vaccinated and receive all their boosters, including the bivalent booster.

Released: 27-Jan-2023 1:25 PM EST
COVID calculations lead to unexpected solution to long-standing problem in theoretical computer science
Universitat Autònoma de Barcelona

At the beginning of the COVID-19 pandemic, Joachim Kock, mathematician at the Universitat Autònoma de Barcelona (UAB), began to experiment with epidemiological models. He did not improve upon the predictions, but unexpectedly he made a mathematical discovery that led to the solution of an old problem in theoretical computer science, open since the 1980s, on Petri nets.

   
Newswise: Study Shows FDA-Approved TB Regimen May Not Work Against the Deadliest Form of TB Due to Multidrug-Resistant Strains
Released: 27-Jan-2023 9:20 AM EST
Study Shows FDA-Approved TB Regimen May Not Work Against the Deadliest Form of TB Due to Multidrug-Resistant Strains
Johns Hopkins Medicine

Johns Hopkins Medicine investigators say their research indicates a new combination of drugs is needed to find an effective treatment for TB meningitis due to multidrug-resistant (MDR) strains

Released: 26-Jan-2023 4:15 PM EST
Small Study Shows Promise for Antimalarial Monoclonal Antibody to Prevent Malaria
University of Maryland School of Medicine

monoclonal antibody treatment was found to be safe, well tolerated, and effective in protecting against malaria in a small group of healthy volunteers who were exposed to malaria in a challenge study, according to new research published in The Lancet Infectious Diseases by researchers at the University of Maryland School of Medicine (UMSOM).

Released: 26-Jan-2023 12:05 PM EST
UT Southwestern biochemist, molecular biologist to receive HHMI Emerging Pathogens awards
UT Southwestern Medical Center

Two of UT Southwestern’s Howard Hughes Medical Institute researchers in biochemistry and molecular biology will lead separate teams as part of HHMI’s Emerging Pathogens Initiative (EPI) targeting infectious diseases that pose a threat to human health.

Newswise: National Primate Research Center of Thailand Chulalongkorn University Symposium 2023
Released: 26-Jan-2023 8:55 AM EST
National Primate Research Center of Thailand Chulalongkorn University Symposium 2023
Chulalongkorn University

As its 11th-anniversary approaches, the National Primate Research Center of Thailand Chulalongkorn University (NPRCT-CU) and the Primates Enterprise Co., Ltd. are pleased to announce two events in February 2023:

Released: 25-Jan-2023 4:55 PM EST
Corona vaccine based on new technology tested in clinical study
Radboud University Medical Centre Nijmegen

A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud university medical center.

Released: 25-Jan-2023 10:05 AM EST
Argonne researchers share in Chicago Innovation Award for COVID wastewater testing
Argonne National Laboratory

Argonne’s expertise in biosafety, genetic sequencing and epidemiology help public health officials track which COVID variants are present in Illinois and monitor variants of concern.

Newswise:Video Embedded stunningly-detailed-blueprint-revealed-of-viral-genome-replication-machinery
VIDEO
Released: 24-Jan-2023 5:05 PM EST
Stunningly detailed blueprint revealed of viral genome replication machinery
Morgridge Institute for Research

Wisconsin virologists have outlined in atomic detail the intricate RNA replication machines that coronaviruses create inside infected cells, giving rise to potential new strategies to fight disease.

   
Newswise: Say Ahhh! Fruit Bat Gets a Check-up in the Republic of Congo
Released: 24-Jan-2023 4:55 PM EST
Say Ahhh! Fruit Bat Gets a Check-up in the Republic of Congo
Wildlife Conservation Society

The Wildlife Conservation Society (WCS) released an image of scientists taking a swab from a straw-colored fruit bat (Eidolon helvum) to test it for zoonotic diseases such as the Ebola virus.

   
Released: 24-Jan-2023 2:40 PM EST
Save children from common cold with higher physical activity
Springer

Higher physical activity levels associated with reduced respiratory infection such as the common cold susceptibility in children.

Released: 23-Jan-2023 5:05 PM EST
Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the Future
Covid-19 Prevention Network (CoVPN)

The federally funded COVID-19 Prevention Network was instrumental in the rapid development of safe, effective and lifesaving COVID-19 vaccines during earlier phases of the pandemic. This vital work to expedite Phase 3 clinical trials also resulted in a 'treasure trove' of data, thanks to a highly collaborative and harmonized approach that can serve as a national and even international model for major research initiatives while also guiding responses to future public health emergencies.

Newswise: Study Comparing Early Interventions for Sepsis Shows Patients Have Identical Outcomes
Released: 23-Jan-2023 4:05 PM EST
Study Comparing Early Interventions for Sepsis Shows Patients Have Identical Outcomes
Vanderbilt University Medical Center

Sepsis can cause dangerously low blood pressure, which is typically treated with intravenous (IV) fluids and/or a vasopressor, a drug that causes constriction of the blood vessels. Whether treatment of sepsis-induced low pressure should primarily be treated with IV fluids or vasopressors has been debated for decades with no clear answer.

Newswise: Host-Cell Factors Involved in COVID-19 Infections May Augur Improved Treatments
Released: 23-Jan-2023 4:00 PM EST
Host-Cell Factors Involved in COVID-19 Infections May Augur Improved Treatments
University of California San Diego

Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.

Released: 23-Jan-2023 3:10 PM EST
Covid-19 in pregnant women can damage the placenta and the fetus
Medical University of Vienna (MedUni Wien)

Using prenatal magnetic resonance imaging, a group of MedUni Vienna researchers examined the placentas and foetuses of women who tested positive for SARS-CoV-2 during pregnancy.

Newswise: Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
Released: 19-Jan-2023 2:35 PM EST
Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
Wistar Institute

amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years.

Newswise: MedStar Washington Hospital Center Opens Biocontainment Unit to Care for Patients Who Contract Highly Infectious Diseases
Released: 19-Jan-2023 11:00 AM EST
MedStar Washington Hospital Center Opens Biocontainment Unit to Care for Patients Who Contract Highly Infectious Diseases
MedStar Washington Hospital Center

MedStar Washington Hospital Center has opened a new state-of-the-art Biocontainment Unit (BCU) to care for patients who contract highly infectious diseases. Located near the Emergency Room, the new multi-purpose 15-bed unit will be used primarily for observation and flexed for respiratory isolation and further flexed to care for patients with highly contagious conditions, such as Ebola.

Newswise: Plague trackers: Researchers cover thousands of years in a quest to understand the elusive origins of the Black Death
18-Jan-2023 9:00 AM EST
Plague trackers: Researchers cover thousands of years in a quest to understand the elusive origins of the Black Death
McMaster University

Seeking to better understand more about the origins and movement of bubonic plague, in ancient and contemporary times, researchers at McMaster University, University of Sydney and the University of Melbourne, have completed a painstaking granular examination of hundreds of modern and ancient genome sequences, creating the largest analysis of its kind.

   
Newswise: International policy adviser, epidemiologist Dr. Saad Omer selected inaugural dean for UT Southwestern’s O’Donnell School of Public Health
Released: 19-Jan-2023 10:00 AM EST
International policy adviser, epidemiologist Dr. Saad Omer selected inaugural dean for UT Southwestern’s O’Donnell School of Public Health
UT Southwestern Medical Center

Internationally recognized epidemiologist Saad B. Omer, M.B.B.S, Ph.D., who currently directs the Yale Institute for Global Health, has been appointed the inaugural Dean of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center.

Newswise: UTSW Pharmacologist James Collins receives 2023 TAMEST Edith and Peter O’Donnell Award
Released: 19-Jan-2023 8:05 AM EST
UTSW Pharmacologist James Collins receives 2023 TAMEST Edith and Peter O’Donnell Award
UT Southwestern Medical Center

James Collins III, Ph.D., Associate Professor of Pharmacology at UT Southwestern Medical Center, will receive the 2023 Edith and Peter O’Donnell Award in Biological Sciences from The Academy of Medicine, Engineering and Science of Texas (TAMEST) for broadening understanding of schistosomiasis.

Newswise: Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production
Released: 18-Jan-2023 7:45 PM EST
Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production
University of California, Los Angeles (UCLA), Health Sciences

New UCLA-led research suggests that antiretroviral drugs called TAF and TDF directly reduce energy production by mitochondria, structures inside cells that generate the power that cells use to function. Both drugs led to reduced cellular oxygen consumption rates, a measure of the ability of the mitochondria to produce energy, compared with controls.

Released: 18-Jan-2023 7:15 PM EST
COVID-19 symptoms 6 months after onset, role of vaccination for SARS-CoV-2 infection
JAMA - Journal of the American Medical Association

In this study of 1,832 U.S. adults, the risk of reporting symptoms for 28 or more days after COVID-19 onset was significantly higher in participants who were unvaccinated at the time of infection and those who reported moderate or severe acute illness symptoms.



close
4.43497